A new technique reported in The FASEB Journal suggests that during early stages, it might be possible to reverse early age-related macular degeneration, a leading cause of blindness that is currently irreversible. The treatment involving a low-energy nanosecond laser may also have further implications for other eye diseases such as diabetic macular edema, diabetic retinopathy and retinopathy of prematurity.
Results showed that treating those with early AMD with this new low energy nanosecond laser may limit disease progression. Importantly, unlike other lasers currently used to treat eye disease, the nanosecond laser does not result in damage to the sensitive retina. This study also showed evidence that nanosecond laser treatment in one eye can also produce positive effects in the other untreated eye. This raises the possibility that monocular treatment may be sufficient to treat disease in both eyes.
For more info: